NCT05983172View on ClinicalTrials.gov

Multi-omics Approach of Risk Stratification for Patients With de Novo Acute Myeloid Leukemia

Enrolling by invitationOBSERVATIONAL

Enrollment

1,500

Participants

Timeline

Start Date

August 31, 2023

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2026

Conditions

Acute Myeloid Leukemia

Trial Locations (1)

100

National Taiwan University Hospital, Taipei

All Listed Sponsors

lead

National Taiwan University Hospital

OTHER